TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
RLAY

Relay Therapeutics Inc

Healthcare · Biotechnology

17.50$ -1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement RLAY
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– – – -96.3% -54.4% +1,749.8% -60.8% +53.4%
– +32.1% +24.7% +4,672.8% +43.5% +34.3% -3.4% -98.9%
– – – -310.3% – – – –
– +71.3% +42.0% +196.1% -16.7% +34.0% -3.3% -18.1%
– +55.2% +180.8% +43.8% +17.3% +14.2% +2.2% -25.4%
– +68.5% +60.5% +47.0% -70.9% +25.2% -7.1% +369.2%
– – – – – – – –
– – – – +961.3% – – –
– – – – – – – –
– -897.2% – – -127.3% – – –
– – – – – – – –
– – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?